Endoscopic Management of Intranasal Pleomorphic Adenoma: A Case Report

Authors : Siti Nursiah; Andrina Y.M. Rambe; Irnanda W.R. Nasution

Volume/Issue : Volume 7 - 2022, Issue 6 - June

Google Scholar : https://bit.ly/3IIfn9N

Scribd : https://bit.ly/3xQGQE6

DOI : https://doi.org/10.5281/zenodo.6642417

Pleomorphic adenoma is one kind of tumor which is the most common benign tumor of major salivary gland tumors. And can occur in the minor salivary gland tissue that can be found in the nasal cavity. Intranasal pleomorphic adenomas are usually formed by the mucous glands of the nasal septum. We found the pathology result of endoscopic surgery. The purpose of this study was to demonstrate an endoscopic approach to surgery for pleomorphic adenoma of the nasal septum. A 34-year-old woman presented with complaints of nasal congestion and occasional bleeding for at least 3 years. We provide treatment with endoscopic surgery to remove the tumor. In this case we ressected the tumor and also the submucous part of the nasal septal to reach tumor-free margins. Microscopic examination shows epithelial tissue, mesenchymal composed of myxoid stroma and also myoepithelial component with H&E staining. The postoperative follow-up of the patient was good, and there were no complications found in the patient. Benign nasal tumors of the minor salivary glands or benign pleomorphic adenomas of the nose are rare tumors and should be considered in their management. A correct histological diagnosis can be confirmed. Treatment for this disease can be done endoscopically endonasal surgery.

Keywords : pleomorphic adenoma, histopathology, nasal septum, endoscopic surgery.


Paper Submission Last Date
31 - March - 2024

Paper Review Notification
In 1-2 Days

Paper Publishing
In 2-3 Days

Video Explanation for Published paper

Never miss an update from Papermashup

Get notified about the latest tutorials and downloads.

Subscribe by Email

Get alerts directly into your inbox after each post and stay updated.

Subscribe by RSS

Add our RSS to your feedreader to get regular updates from us.